Psychological assessment of primary aldosteronism: a controlled study

N Sonino, E Tomba, ML Genesia… - The Journal of …, 2011 - academic.oup.com
N Sonino, E Tomba, ML Genesia, C Bertello, P Mulatero, F Veglio, GA Fava, F Fallo
The Journal of Clinical Endocrinology & Metabolism, 2011academic.oup.com
Objective: Our objective was to investigate psychological correlates in a population with
primary aldosteronism (PA) using methods found to be sensitive and reliable in
psychosomatic research. Methods: Twenty-three PA patients (12 male, 11 female; mean age
50±9 yr) were compared with 23 patients with essential hypertension (EH)(15 male, eight
female; mean age 47±8 yr) and 23 matched normotensive subjects. A modified version of
the Structural Clinical Interview for DSM-IV, a shortened version of the structured interview …
Objective
Our objective was to investigate psychological correlates in a population with primary aldosteronism (PA) using methods found to be sensitive and reliable in psychosomatic research.
Methods
Twenty-three PA patients (12 male, 11 female; mean age 50 ± 9 yr) were compared with 23 patients with essential hypertension (EH) (15 male, eight female; mean age 47 ± 8 yr) and 23 matched normotensive subjects. A modified version of the Structural Clinical Interview for DSM-IV, a shortened version of the structured interview for the Diagnostic Criteria for Psychosomatic Research, and two self-rating questionnaires, the Psychosocial Index and the Symptom Questionnaire, were administered.
Results
Twelve of 23 patients with PA (52.2%) suffered from an anxiety disorder compared with four of 23 with EH (17.4%) and one control (4.3%) (P < 0.001). Generalized anxiety disorder was more frequent in PA than in EH patients and controls (P < 0.05). As assessed by Diagnostic Criteria for Psychosomatic Research, irritable mood was more frequent in PA and EH compared with controls (P < 0.05) but did not differentiate PA from EH. According to Psychosocial Index results, patients with PA had higher levels of stress (P < 0.01) and psychological distress (P < 0.01) and lower level of well-being (P < 0.05) than controls. Compared with EH patients, PA patients had higher scores in stress subscale (P < 0.05). The Symptom Questionnaire showed higher levels of anxiety (P < 0.01), depression (P < 0.01) and somatization (P < 0.01) and lower physical well-being (P < 0.05) in PA than controls.
Conclusion
A role of mineralocorticoid regulatory mechanisms in clinical situations concerned with anxiety and stress is suggested.
Oxford University Press